IBDEI05H ; ; 19-NOV-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7065,1,4,0)
 ;;=4^285.21
 ;;^UTILITY(U,$J,358.3,7065,1,5,0)
 ;;=5^Anemia In Renal Dis
 ;;^UTILITY(U,$J,358.3,7065,2)
 ;;=^321977
 ;;^UTILITY(U,$J,358.3,7066,0)
 ;;=285.29^^40^473^9
 ;;^UTILITY(U,$J,358.3,7066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7066,1,4,0)
 ;;=4^285.29
 ;;^UTILITY(U,$J,358.3,7066,1,5,0)
 ;;=5^Anemia Of Chronic Dis
 ;;^UTILITY(U,$J,358.3,7066,2)
 ;;=^321979
 ;;^UTILITY(U,$J,358.3,7067,0)
 ;;=284.9^^40^473^10
 ;;^UTILITY(U,$J,358.3,7067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7067,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,7067,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,7067,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,7068,0)
 ;;=282.61^^40^473^75
 ;;^UTILITY(U,$J,358.3,7068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7068,1,4,0)
 ;;=4^282.61
 ;;^UTILITY(U,$J,358.3,7068,1,5,0)
 ;;=5^Hemoglobin S Disease
 ;;^UTILITY(U,$J,358.3,7068,2)
 ;;=^267981
 ;;^UTILITY(U,$J,358.3,7069,0)
 ;;=282.7^^40^473^74
 ;;^UTILITY(U,$J,358.3,7069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7069,1,4,0)
 ;;=4^282.7
 ;;^UTILITY(U,$J,358.3,7069,1,5,0)
 ;;=5^Hemoglobin C Disease
 ;;^UTILITY(U,$J,358.3,7069,2)
 ;;=^87629
 ;;^UTILITY(U,$J,358.3,7070,0)
 ;;=283.9^^40^473^76
 ;;^UTILITY(U,$J,358.3,7070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7070,1,4,0)
 ;;=4^283.9
 ;;^UTILITY(U,$J,358.3,7070,1,5,0)
 ;;=5^Hemolytic Anemia,Acquired
 ;;^UTILITY(U,$J,358.3,7070,2)
 ;;=^7071
 ;;^UTILITY(U,$J,358.3,7071,0)
 ;;=283.0^^40^473^77
 ;;^UTILITY(U,$J,358.3,7071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7071,1,4,0)
 ;;=4^283.0
 ;;^UTILITY(U,$J,358.3,7071,1,5,0)
 ;;=5^Hemolytic Anemia,Autoimmune
 ;;^UTILITY(U,$J,358.3,7071,2)
 ;;=^7079
 ;;^UTILITY(U,$J,358.3,7072,0)
 ;;=282.9^^40^473^78
 ;;^UTILITY(U,$J,358.3,7072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7072,1,4,0)
 ;;=4^282.9
 ;;^UTILITY(U,$J,358.3,7072,1,5,0)
 ;;=5^Hemolytic Anemia,Hereditary
 ;;^UTILITY(U,$J,358.3,7072,2)
 ;;=^56578
 ;;^UTILITY(U,$J,358.3,7073,0)
 ;;=283.19^^40^473^79
 ;;^UTILITY(U,$J,358.3,7073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7073,1,4,0)
 ;;=4^283.19
 ;;^UTILITY(U,$J,358.3,7073,1,5,0)
 ;;=5^Hemolytic Anemia,Microang
 ;;^UTILITY(U,$J,358.3,7073,2)
 ;;=^293664
 ;;^UTILITY(U,$J,358.3,7074,0)
 ;;=280.9^^40^473^83
 ;;^UTILITY(U,$J,358.3,7074,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7074,1,4,0)
 ;;=4^280.9
 ;;^UTILITY(U,$J,358.3,7074,1,5,0)
 ;;=5^Iron Defic Anemia(Unspecified)
 ;;^UTILITY(U,$J,358.3,7074,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,7075,0)
 ;;=285.1^^40^473^81
 ;;^UTILITY(U,$J,358.3,7075,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7075,1,4,0)
 ;;=4^285.1
 ;;^UTILITY(U,$J,358.3,7075,1,5,0)
 ;;=5^Iron Defic Anemia Due To Acute Blood Loss
 ;;^UTILITY(U,$J,358.3,7075,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,7076,0)
 ;;=280.0^^40^473^82
 ;;^UTILITY(U,$J,358.3,7076,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7076,1,4,0)
 ;;=4^280.0
 ;;^UTILITY(U,$J,358.3,7076,1,5,0)
 ;;=5^Iron Defic Anemia Due To Chronic Blood Loss
 ;;^UTILITY(U,$J,358.3,7076,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,7077,0)
 ;;=281.9^^40^473^106
 ;;^UTILITY(U,$J,358.3,7077,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7077,1,4,0)
 ;;=4^281.9
 ;;^UTILITY(U,$J,358.3,7077,1,5,0)
 ;;=5^Nutritional Anemia
 ;;^UTILITY(U,$J,358.3,7077,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,7078,0)
 ;;=281.0^^40^473^120
 ;;^UTILITY(U,$J,358.3,7078,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7078,1,4,0)
 ;;=4^281.0
 ;;^UTILITY(U,$J,358.3,7078,1,5,0)
 ;;=5^Vit B12 Deficiency (Pernicious Anemia)
 ;;^UTILITY(U,$J,358.3,7078,2)
 ;;=^7161
 ;;^UTILITY(U,$J,358.3,7079,0)
 ;;=282.60^^40^473^110
 ;;^UTILITY(U,$J,358.3,7079,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7079,1,4,0)
 ;;=4^282.60
 ;;^UTILITY(U,$J,358.3,7079,1,5,0)
 ;;=5^Sickle-Cell Anemia
 ;;^UTILITY(U,$J,358.3,7079,2)
 ;;=^7188
 ;;^UTILITY(U,$J,358.3,7080,0)
 ;;=282.62^^40^473^111
 ;;^UTILITY(U,$J,358.3,7080,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7080,1,4,0)
 ;;=4^282.62
 ;;^UTILITY(U,$J,358.3,7080,1,5,0)
 ;;=5^Sickle-Cell With Crisis
 ;;^UTILITY(U,$J,358.3,7080,2)
 ;;=^267982
 ;;^UTILITY(U,$J,358.3,7081,0)
 ;;=281.1^^40^473^121
 ;;^UTILITY(U,$J,358.3,7081,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7081,1,4,0)
 ;;=4^281.1
 ;;^UTILITY(U,$J,358.3,7081,1,5,0)
 ;;=5^Vit B12 Deficiency(Dietary)
 ;;^UTILITY(U,$J,358.3,7081,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,7082,0)
 ;;=286.7^^40^473^52
 ;;^UTILITY(U,$J,358.3,7082,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7082,1,4,0)
 ;;=4^286.7
 ;;^UTILITY(U,$J,358.3,7082,1,5,0)
 ;;=5^Coagulation Defect(Any),Acquired
 ;;^UTILITY(U,$J,358.3,7082,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,7083,0)
 ;;=289.9^^40^473^117
 ;;^UTILITY(U,$J,358.3,7083,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7083,1,4,0)
 ;;=4^289.9
 ;;^UTILITY(U,$J,358.3,7083,1,5,0)
 ;;=5^Thrombocytosis, Essential
 ;;^UTILITY(U,$J,358.3,7083,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,7084,0)
 ;;=451.9^^40^473^118
 ;;^UTILITY(U,$J,358.3,7084,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7084,1,4,0)
 ;;=4^451.9
 ;;^UTILITY(U,$J,358.3,7084,1,5,0)
 ;;=5^Thrombophlebitis 
 ;;^UTILITY(U,$J,358.3,7084,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,7085,0)
 ;;=446.6^^40^473^119
 ;;^UTILITY(U,$J,358.3,7085,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7085,1,4,0)
 ;;=4^446.6
 ;;^UTILITY(U,$J,358.3,7085,1,5,0)
 ;;=5^Thrombotic Thrombocytopenic Purpura(Ttp)
 ;;^UTILITY(U,$J,358.3,7085,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,7086,0)
 ;;=286.4^^40^473^122
 ;;^UTILITY(U,$J,358.3,7086,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7086,1,4,0)
 ;;=4^286.4
 ;;^UTILITY(U,$J,358.3,7086,1,5,0)
 ;;=5^Von Willebrand's Disease
 ;;^UTILITY(U,$J,358.3,7086,2)
 ;;=^127267
 ;;^UTILITY(U,$J,358.3,7087,0)
 ;;=204.00^^40^473^1
 ;;^UTILITY(U,$J,358.3,7087,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7087,1,4,0)
 ;;=4^204.00
 ;;^UTILITY(U,$J,358.3,7087,1,5,0)
 ;;=5^ALL w/o Remission
 ;;^UTILITY(U,$J,358.3,7087,2)
 ;;=^267521
 ;;^UTILITY(U,$J,358.3,7088,0)
 ;;=204.01^^40^473^2
 ;;^UTILITY(U,$J,358.3,7088,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7088,1,4,0)
 ;;=4^204.01
 ;;^UTILITY(U,$J,358.3,7088,1,5,0)
 ;;=5^ALL,In Remission
 ;;^UTILITY(U,$J,358.3,7088,2)
 ;;=^267522
 ;;^UTILITY(U,$J,358.3,7089,0)
 ;;=204.10^^40^473^13
 ;;^UTILITY(U,$J,358.3,7089,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7089,1,4,0)
 ;;=4^204.10
 ;;^UTILITY(U,$J,358.3,7089,1,5,0)
 ;;=5^CLL w/o Remission
 ;;^UTILITY(U,$J,358.3,7089,2)
 ;;=^267523
 ;;^UTILITY(U,$J,358.3,7090,0)
 ;;=204.11^^40^473^14
 ;;^UTILITY(U,$J,358.3,7090,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7090,1,4,0)
 ;;=4^204.11
 ;;^UTILITY(U,$J,358.3,7090,1,5,0)
 ;;=5^CLL,In Remission
 ;;^UTILITY(U,$J,358.3,7090,2)
 ;;=^267524
 ;;^UTILITY(U,$J,358.3,7091,0)
 ;;=201.90^^40^473^80
 ;;^UTILITY(U,$J,358.3,7091,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7091,1,4,0)
 ;;=4^201.90
 ;;^UTILITY(U,$J,358.3,7091,1,5,0)
 ;;=5^Hodgkin's Lymphoma,Unspec Type/Site
 ;;^UTILITY(U,$J,358.3,7091,2)
 ;;=^267430
 ;;^UTILITY(U,$J,358.3,7092,0)
 ;;=785.6^^40^473^87
 ;;^UTILITY(U,$J,358.3,7092,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7092,1,4,0)
 ;;=4^785.6
 ;;^UTILITY(U,$J,358.3,7092,1,5,0)
 ;;=5^Lymphadenopathy
 ;;^UTILITY(U,$J,358.3,7092,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,7093,0)
 ;;=200.20^^40^473^89
 ;;^UTILITY(U,$J,358.3,7093,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7093,1,4,0)
 ;;=4^200.20
 ;;^UTILITY(U,$J,358.3,7093,1,5,0)
 ;;=5^Lymphoma, Burkitt's, Unspecified Sites
 ;;^UTILITY(U,$J,358.3,7093,2)
 ;;=^17529
 ;;^UTILITY(U,$J,358.3,7094,0)
 ;;=202.00^^40^473^91
 ;;^UTILITY(U,$J,358.3,7094,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7094,1,4,0)
 ;;=4^202.00
 ;;^UTILITY(U,$J,358.3,7094,1,5,0)
 ;;=5^Lymphoma, Low-Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,7094,2)
 ;;=^72606
 ;;^UTILITY(U,$J,358.3,7095,0)
 ;;=200.10^^40^473^90
 ;;^UTILITY(U,$J,358.3,7095,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7095,1,4,0)
 ;;=4^200.10
 ;;^UTILITY(U,$J,358.3,7095,1,5,0)
 ;;=5^Lymphoma, Int Or High Grade, Unspec Site
 ;;^UTILITY(U,$J,358.3,7095,2)
 ;;=^175886
 ;;^UTILITY(U,$J,358.3,7096,0)
 ;;=273.3^^40^473^92
 ;;^UTILITY(U,$J,358.3,7096,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7096,1,4,0)
 ;;=4^273.3
 ;;^UTILITY(U,$J,358.3,7096,1,5,0)
 ;;=5^Macroglobulinemia
 ;;^UTILITY(U,$J,358.3,7096,2)
 ;;=^73013
 ;;^UTILITY(U,$J,358.3,7097,0)
 ;;=203.00^^40^473^104
 ;;^UTILITY(U,$J,358.3,7097,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7097,1,4,0)
 ;;=4^203.00
 ;;^UTILITY(U,$J,358.3,7097,1,5,0)
 ;;=5^Multiple Myeloma w/o Remission
 ;;^UTILITY(U,$J,358.3,7097,2)
 ;;=^267514
 ;;^UTILITY(U,$J,358.3,7098,0)
 ;;=203.01^^40^473^103
 ;;^UTILITY(U,$J,358.3,7098,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7098,1,4,0)
 ;;=4^203.01
 ;;^UTILITY(U,$J,358.3,7098,1,5,0)
 ;;=5^Multiple Myeloma In Remission
 ;;^UTILITY(U,$J,358.3,7098,2)
 ;;=^267515
 ;;^UTILITY(U,$J,358.3,7099,0)
 ;;=238.6^^40^473^107
 ;;^UTILITY(U,$J,358.3,7099,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7099,1,4,0)
 ;;=4^238.6
 ;;^UTILITY(U,$J,358.3,7099,1,5,0)
 ;;=5^Plasmacytoma MOS
 ;;^UTILITY(U,$J,358.3,7099,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,7100,0)
 ;;=205.00^^40^473^3
 ;;^UTILITY(U,$J,358.3,7100,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7100,1,4,0)
 ;;=4^205.00
 ;;^UTILITY(U,$J,358.3,7100,1,5,0)
 ;;=5^AML w/o Remission
 ;;^UTILITY(U,$J,358.3,7100,2)
 ;;=^267531
 ;;^UTILITY(U,$J,358.3,7101,0)
 ;;=205.01^^40^473^4
 ;;^UTILITY(U,$J,358.3,7101,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7101,1,4,0)
 ;;=4^205.01
 ;;^UTILITY(U,$J,358.3,7101,1,5,0)
 ;;=5^AML,In Remission
 ;;^UTILITY(U,$J,358.3,7101,2)
 ;;=^267532
 ;;^UTILITY(U,$J,358.3,7102,0)
 ;;=205.10^^40^473^15
 ;;^UTILITY(U,$J,358.3,7102,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,7102,1,4,0)
 ;;=4^205.10
 ;;^UTILITY(U,$J,358.3,7102,1,5,0)
 ;;=5^CML w/o Remission
 ;;^UTILITY(U,$J,358.3,7102,2)
 ;;=^267533
